(415 days)
Not Found
Not Found
No
The summary describes a purely mechanical device for surgical stabilization and does not mention any computational or data-driven components.
No
The device is described as providing a mechanical means for immobilization, isolation, and occlusion during surgery. It does not treat or cure a disease or condition.
No
The device is described as providing "mechanical means for immobilization of the anastomotic site on a beating heart and provides coronary artery isolation and occlusion by compression," indicating it is a surgical tool for stabilization and occlusion, not for diagnosing conditions.
No
The device description clearly indicates a physical pad used on a heart stabilizer unit, which is a hardware component.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that the device is used on a heart stabilizer unit during coronary bypass surgery to mechanically immobilize and isolate the anastomotic site on a beating heart. This is a surgical procedure performed in vivo (within the living body).
- IVD Definition: In Vitro Diagnostics (IVDs) are medical devices used to examine specimens derived from the human body (like blood, urine, tissue) outside the body to provide information for diagnosis, monitoring, or screening.
The Heart Stabilizer Pad is a surgical tool used directly on the organ during surgery, not for testing samples outside the body.
N/A
Intended Use / Indications for Use
The Heart Stabilizer Pad is used on an appropriate heart stabilizer unit for coronary bypass surgery. It provides a mechanical means for immobilization of the anastomotic site on a beating heart and provides coronary artery isolation and occlusion by compression.
Product codes
MMS
Device Description
Not Found
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Heart
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Not Found
Key Metrics
Not Found
Predicate Device(s)
Not Found
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.4500 Cardiovascular surgical instruments.
(a)
Identification. Cardiovascular surgical instruments are surgical instruments that have special features for use in cardiovascular surgery. These devices include, e.g., forceps, retractors, and scissors.(b)
Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9.
0
Image /page/0/Picture/2 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized image of an eagle's head and neck, with three curved lines representing the body. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle image.
SEP 1 3 2000
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Mr. Mosaddeq Hossain Regulatory Affairs/Quality Assurance Pilling Weck Surgical 420 Delaware Drive Fort Washington, PA 19034 .
K992476 Re: Pilling Weck Surgical Stabilizer Removable Pads Trade Name: Regulatory Class: I (one) Product Code: MMS Dated: June 13, 2000 Received: June 15, 2000
Dear Mr. Hossain:
We have reviewed your Section 510(k) notification of intent to market the we have reviewed your boose. The determined the device is device referenced above and we nate accessions for use stated in the substantially equivalenc (for the endress marketed in interstate enclosure) to legally marketed produce ment date of the Medical Device commerce prior to May 20, 1970, che character in accordance with Amendments, of to devices chat have book and Cosmetic Act (Act) . You
the provisions of the Federal Food, Drug, and Cosmetic controle the provisions of the reacturies, subject to the general controls may, therefore, market the device, canfrols provisions of the Act, provisions of the Act. The general consisted plasting of devices, good include requirements for annual regiording, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special If your device Is Classifica (boo aboroval), it may be subject to such Controls) of Class III (Fremaries opproventions affecting your device additional controls. Extreme major boysations, Title 21, Parts 800 to e found in the oodeuivalent determination assumes compliance with 895. 895. A substantially equivalence active requirements, as set forth in the the Current Good Manufacturing Fracesses al copices: General regulation Quarity System Regulacion (20) 2021 periodic QS inspections, the Food and (21 CFR Parc 820) and that, chrough pouch assumptions. Failure to comply
Drug Administration (FDA) will verify such assumption - In addition Drug Administration (result in regulatory action. In addition,
with the GMP regulation may result in regulatory device in the with the GMF regulation may reserved to concerning your device in the For may publicity . Please note: this response to your premarket rederal Register. Frease not affect any obligation you might have noctricacion basis of the Act for devices under the under sections 551 through 312 or other Federal laws or requlations.
1
This letter will allow you to begin marketing your device as described in Inis leccer will arrow you se-blash. The FDA finding of substantial your Jro(k) premail.or not to a legally marketed predicate device results equivalence or your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic (Zi Crk rate oor and addression fire of Compliance at (301) 594-4586. additionally, for questions on the promotion and advertising of your Audicionally, for quoberne to compliance at (301) 594-4639. Also, alease note the regulation entitled, "Misbranding by reference to Other general information on premarket notification" (21CFR 807.97). premarked notification (Eroste act may be obtained from the Division of your responsibilities and its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".
. Sincerely yours,
James E. Dillard III
ames E. Dillard III Director Division of Cardiovascular and Respiratory Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
510(K) Number (if known):
Device Name: Pilling Weck Surgical Heart Stabilizer Removable Pads
Indications for Use:
The Heart Stabilizer Pad is used on an appropriate heart stabilizer unit for coronary bypass surgery. It provides a mechanical means for immobilization of the anastomotic site on a beating heart and provides coronary artery isolation and occlusion by compression.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Kathi Miller
(Division Sign. Division of Cardiovascular, Respiratory, and Neurological De 510(k) Number
Prescription Use _X
The-Counter Use-$\times$
(Per 21 CFR 801.1 09)
or Over-